GLN-ATOVAQUONE
Google image searchProduct monograph
Active ingredient
atovaquone, 750 MG/5 ML
DIN: 02528495
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 30-JUN-2022
ATC:
- P01 — ANTIPROTOZOALS (ATC, ATC/DDD, )
- P01A — AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES (ATC, ATC/DDD)
- P01AX — Other agents against amoebiasis and other protozoal diseases (ATC, ATC/DDD)
- P01AX06 — ATOVAQUONE (ATC/DDD)
Reference brand drug: Mepron
Pharmaceutical standard: USP
